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Abstract: Variations in anxiety-related behavior are associated with individual allostatic set-points in
chronically stressed rats. Actively offensive rats with the externalizing indicators of sniffling
and climbing the stimulus and material tearing during 10 days of predator scent stress had
reduced plasma corticosterone, increased striatal glutamate metabolites, and increased adrenal
11-dehydrocorticosterone content compared to passively defensive rats with the internalizing
indicators of freezing and grooming, as well as to controls without any behavioral changes.
These findings suggest that rats that display active offensive activity in response to stress develop
anxiety associated with decreased allostatic set-points and increased resistance to stress.
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1. Introduction
In the fight for survival, stress-related psychobiological responses are activated together with
calming mechanisms [1,2]. Some authors have referred to these adaptive processes as “active (ACS)
or passive (PCS) coping styles” [1], while others have described them as active offensive (AOR) or
passive defensive responses (PDR). Using a description related to the allostasis paradigm, one may
also refer, correspondingly, to the allostatic flight/fight/active (AFR) or allostatic freezing/passive (APR)
responses [3]. The AFR involves offensive and proactive investigatory reactions toward environmental
threats or stressors, a more aggressive phenotype, and a less pronounced neural and physiological
response to stress than the APR. While some researchers have focused on the biological basis of
these styles, including hormonal changes, neural remodeling, and gene methylation processes [4–6],
others have pointed out the importance of individual differences in these responses [7–9]. The exact
underlying mechanisms of these different psychobiological processes, including genetic and epigenetic
changes, are unclear [10–15].
Circulating predator scent stress (PSS) glucocorticoid (GC) levels may vary with the different
behavioral responses to stress. Thus, in a rat model of chronic PSS, lower plasma GCs were associated
with active rather than passive responder animals [1,3]. Similarly, in other animal models of active
and passive biobehavioral responses leading to calming down on stress, different allostatic set-points
were observed with high and low circulating GC levels, respectively [5,16]. Furthermore, in the
forced swim test, rats given subcutaneous injections of corticosterone (CORT) displayed more passive
responding and depression-like behaviors than controls [17]. Taken together, these data suggest that
elevated circulating CORT levels may play a causal role in promoting passive rather than active styles
of responding.
The amygdala, prefrontal cortex (PFC), and ventral striatum are consistent components of the
stress response, including synaptic interactions between one of the most important neurotransmitters,
i.e., glutamate (Glu), and the circulating levels of CORT [18–22]. While most studies have focused on the
circuits between the amygdala and PFC, they have neglected the modulatory role of striatum in the stress
response, even when GCs administered directly into the dorsal striatum lead to enhanced consolidation
of inhibited avoidance memory in cued water-maze training [23–26]. Finally, the striatum was linked to
individual differences in the organism’s response to stress, with “active coping” associated with striatal
activation, as indicated by a heightened glucose uptake in this region during stress [27]. Aside from
striatal changes, peculiarities in CORT reduction pathways may contribute to variations in the stress
response. The first pathway of CORT reduction reflects limbic–hypothalamic–pituitary–adrenal (LHPA)
axis suppression, which is in concordance with reduction of glucose uptake in the hypothalamus of
AFR rats [27].
The second pathway may be linked to tissue metabolism of GCs by the 11β hydroxysteroid
dehydrogenases (11βHSD) type 1 (11βHSD1) and type 2 (11βHSD2), which are involved in the
interconversion between active and inactive forms of GCs, depending on the tissue. Thus, the active
form of CORT is metabolized by 11βHSD2 to the inactive form 11-dehydrocorticosterone, while the
reverse reaction from an inactive to an active form is catalyzed by the 11βHSD type 1 enzyme [28,29].
The adrenal cortices express both 11βHSD1 and 11βHSD2, which may be involved in not only
activating, but also inactivating, calming reactions of the stress response. This suggests that the latter
may also take place at the level of the end-organ of the LHPA axis, possibly via a regulated decrease of
active GC secretion.
In post-traumatic stress disorder (PTSD), traumatic memories activate the striatum and inactivate
the hippocampus, leading to a shift from hippocampal to striatal memory [30,31]. Indeed, functional
magnetic resonance imaging (fMRI) studies in PTSD have demonstrated hippocampal–striatal
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hyperconnectivity, with lack of adaptability and decreased inter-regulation between the two regions [32].
Interestingly, reduced striatum reactivity was associated with increased vulnerability to stress
in individuals exposed to early-life stress [33,34]. The effects of the latter on behavioral and
striatal development have been well described and include both externalizing and internalizing
symptoms [35,36]. Antidepressant-treatment-dependent increases in positive affect in depressed
patients can be explained by an increase in sustained nucleus accumbens activity, while reductions
of positive affect in this disorder may result in part from loss of the ability to sustain nucleus
accumbens activity and connectivity with the fronto-striatal region over time [36]. Adolescents with
high aggressiveness exhibited striatal activation during both reward and nonreward phases, whereas
healthy controls exhibited striatal activation only during reward, shifting to anterior cingulate activation
during nonreward [37].
The genotype/phenotype/endophenotype of individual differences in the psychobiological stress
response is of importance and may shed light on the phenomenon of insufficient effectiveness of
available therapies for depression and PTSD. According to Taghzouti et al., the antidepressant fluoxetine
was effective in only a subgroup of low-stress- but not high-stress-responder rats [38]. These results were
confirmed and extended with other drugs, such as desipramine [39] and citalopram or reboxetine [40],
which revealed distinct effects of drugs depending on the interindividual differences of allostatic
set-points of stress. In light of the above considerations, we examined whether active and passive
responses to chronic predator scent test were associated with different allostatic set-points by measuring
plasma CORT, striatum Glu metabolites, and adrenal gland CORT and 11-dehydrocorticosterone content.
We predicted LHPA axis alterations associated with increased striatal and decreased adrenocortical
activity in chronically stressed AFR rats compared to APR or control rats.
2. Results
2.1. Behavior on Exposure to Stimuli (Kruskal–Wallis One-Way/Bonferroni Post Hoc Tests)
Following exposure to the predator odor stimulus, the rat phenotypic behavioral pattern was
classified into one of two groups: allostatic flight/fight response (AFR) and allostatic freezing/passive
response (APR). AFR phenotypic behavioral pattern was established in 45% of the animals, and APR in
the remaining 55%. In general, climbing, sniffing, and tearing in AFR rats and freezing and grooming
in APR rats prevailed in the direct response behavior to stress stimuli, while control rats within their
cages demonstrated neutral behavioral patterns. Significant differences between AFR and APR rats
were observed in the summarized number of freezing (H2,26 = 15.75; p < 0.001), grooming (H2,26 = 8.85;
p = 0.012), sniffing (H2,26 = 18.88; p < 0.001), and climbing (H2,26 = 15.17; p < 0.001) acts, as well as in
the tearing the protective material of the Petri dishes (H2,26 = 15.47; p < 0.001) acts (Figure 1).
After 10 days of PSS induction, hetero-chronic changes were revealed in AFR rats, which manifested
a rise in climbing (with peaks on days 1–3 and 6–7; Figure 1d) and sniffing acts (with peaks on days 1–5
and 9–10; Figure 1c) and episodes of tearing/aggressive behavior (day 1–6; Figure 1e) in comparison to
APR rats. AFR rats displayed decreased frequency of freezing on days 2 and 5–6 in comparison to APR
rats (Figure 1a), while the latter demonstrated higher numbers of grooming behavior acts on days 7 and
9 in comparison to AFR animals (Figure 1b). In AFR rats, an upward trend in the incidence of grooming
was determined (the number of grooming acts at the final stages of the experiment exceeded the ones
of the initial stages). Thus, in the dynamics of 10-day PSS, only the aggressiveness was characterized
by the presence of traits in AFR rats, with complete absences in APR rats. Other characteristics
were revealed in both phenotypes, although with different intensities. This is why we identified
the dominant behavioral patterns in the two phenotypes of rats, evaluating the differences in the
summarized numbers of behavioral acts during the 10 days of PSS exposure.













Figure 1. Behavior patterns of allostatic flight/fight/active (AFR) or allostatic freezing/passive (APR)
response rats. Legend: Bonferroni’s calculations for M ± SE of (a) the frequency (per rat) of freezing
behavior acts, (b) the frequency (per rat) of grooming behavior acts, (c) The frequency (per rat) of
sniffing acts, (d) the frequency (per rat) of climbing acts, (e) the frequency (per rat) of attempts to tear
the protective material of the Petri dishes.
2.2. AFR and APR Rat Behavior in Elevated Plus Maze
A significant influence of the behavioral phenotype in response to PSS on the cumulative number
of entries (F2,26 = 12.84; p < 0.001), exploring (F2,26 = 14.3; p < 0.001), and time spent in the open
(OA) (F2,26 = 21.04; p < 0.0001) and closed arms (CA) (F2,26 = 23.04; p < 0.0001) was revealed (Table 1).
According to the results, PSS led to a rise in OA entries (p = 0.0025 vs. control; p = 0.001 vs. APR),
OA exploring, and time spent in OA (p = 0.00007 vs. control; p = 0.0001 vs. APR) and CA (p = 0.0001
vs. control; p < 0.0001 vs. APR) in the AFR compared to APR and unstressed control rats. Overall,
the different behavioral phenotypes in response to PSS exposures were characterized by the distinctions
in animal anxiety levels on day 14 post PSS cessation: diminished anxiety levels were observed only in
AFR rats.
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Table 1. Behavioral performance of AFR and APR rats in elevated plus maze test.
Control APR AFR
Central square time 0.10 ± 0.02 0.12 ± 0.02 0.19 ± 0.01 *,#
% Closed arms time 0.89 ± 0.03 0.8 ± 0.03 0.62 ± 0.03 *,#
% Open arms time 0.11 ± 0.01 0.08 ± 0.01 0.19 ± 0.03 *,#
Entries into open arms 1.32 ± 0.24 1.15 ± 0.024 4.42 ± 0.45 *,#
Entries into closed arms 4.55 ± 0.78 8.68 ± 1.25 5.43 ± 0.35
Legend: Data presented using M ± SD; * p < 0.05 in comparison with control (n = 8); # p < 0.05 AFR (n = 9) in
comparison with APR (n = 12).
2.3. Biochemical Differences in Our Classified Behavioral Subtypes
Magnetic resonance spectroscopy (MRS) analysis using a one-way ANOVA (Figure 2) revealed
significant differences in summarized Glu+glutamine (Gln) metabolites in striatum (F2,26 = 6.97;
p < 0.001), with higher Glu+Gln levels in AFR (24.94 ± 9.51%, n = 9) than in APR rats (17.02 ± 5.19%,
n = 12; p < 0.005) and when compared with control rats (16.37 ± 3.35%; p < 0.005), while there were no
differences in Glu+Gln levels in APR rats in comparison to control animals.
 
Figure 2. Long-term consequences of predator scent stress (PSS) in rat striatum. Legend: Total
metabolite (%) glutamate+glutamine concentrations. * p < 0.05 in comparison with APR (n = 12);
# p < 0.05 AFR (n = 9) in comparison with control.
Even 18 days after PSS induction (Figure 3a), differences in plasma CORT levels were significant
(F2,26 = 6.71; p < 0.01): hormone levels in AFR rats (16.61 ± 6.59 ng/mL, n = 9) were lower than in APR
(58.63 ± 23.54 ng/mL, n = 12; p = 0.007) and control animals (41.18 ± 17.23 ng/mL, n = 8; p = 0.049),
while no differences were revealed between APR and control animals.
The adrenal concentrations of CORT and 11-dehydrocorticosterone (as an inactivated derivative
of CORT) were examined to evaluate the balance between GC production and inactivation in AFR and
APR rats 18 days post PSS cessation. The analysis, conducted via a one-way ANOVA, did not reveal
any significant effects of the behavioral response to PSS on CORT (F2,26 = 0.74; p = 0.52); however,
11-dehydrocorticosterone levels (Figure 3b) were different (F2,26 = 3.7; p = 0.041) between either group
of stressed rats (AFR and APR) and controls: AFR rats (0.85 ± 0.13 ng/mg, n = 9) were characterized
by higher 11-dehydrocorticosterone levels than APR (0.66 ± 0.049 ng/mg, n = 12; p = 0.0006) and
control (0.69 ± 0.11 ng/mg, n = 8; p = 0.019) rats, while the 11-dehydrocorticosterone level reduction in
APR was similar to that of the control (p = 0.25) rats. Moreover, the 11-dehydrocorticosterone/CORT
ratio was different (F2,26 = 3.7; p = 0.041) between both groups of stressed rats (AFR and APR).
AFR rats (35.04 ± 11.25 n = 9) were characterized by lower CORT/11-dehydrocorticosterone ratio than
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APR (55.16 ± 16.12 n = 12; p = 0.0006) and control rats (52.33 ± 18.25; n = 8; p = 0.033), while the




Figure 3. Comparison of peripheral corticosteroids 18 days after PSS. Legend: (a) Plasma CORT levels
(ng/mL) and (b) adrenal 11-dehydrocorticosterone levels (ng/mg of tissue). # p < 0.05 AFR (n = 9) in
comparison to APR (n = 12).); * p < 0.05 in comparison to control (n = 8).
3. Discussion
The results obtained in this study allowed us to propose a link between “coping style” and related
behavioral patterns in PSS exposure. Thus, animals with an offensive response to chronic predator
stress (AFR) not only exhibited the lowest anxiety levels in response to the stressor [3], but also had
higher striatal glutamate metabolite concentrations, as well as lower basal plasma CORT, and higher
11-dehydrocorticosterone in the adrenal glands than APR rats and controls. This observation is
consistent with our previous data, where the anxiety extinction after stress exposure, accompanied
by higher lactate (lac) and lower Glu levels in the amygdala, another main driver of the anxiety
response [18–22,41] as observed in AFR animals [3]. Taken together, our results suggest a novel
mechanism of transient hypocorticosteronemia in tissues, with corticosterone being suppressed in
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situ in the adrenal glands. It is important that this is reversible and that the pool of the synthesized






Figure 4. Parallel behavioral and brain biochemical changes in AFR rats. Legend:
Hypocorticosteronemia in AFR rats develops as a result of corticosterone inactivation by 11βHSD2
in the adrenal glands. Low corticosterone levels contribute to inhibition of amygdala activity, which
manifests as a decrease in glutamate (Glu)/glutamine (Gln) ratio and an increase in lactate (Lac) in
this brain structure [3]. A parallel increase in the excitatory neurotransmitter Glu+Gln in the striatum
possibly indicates activation of this brain structure. Inhibition of the amygdala and activation of the
striatum possibly lead to a decrease in the anxiety of AFR rats. The observed decrease in corticosterone
is most likely transient and rapidly restorable. The red stars indicated “R-Gcs” (Gluccocorticoid
receptors of the amygdala).
Granted that active coping style pertains to the flight/fight response, while passive coping style
corresponds to freezing/passive response [1,5,16], it makes sense that high CORT levels in APR
animals are associated with a passive coping strategy. This is in agreement with data in primates and
rodents, in which high basal and stress-induced cortisol levels have been associated with increased
freezing [42,43]. Similarly, preventing CORT release in newborn rats by removing the adrenals leads to
impaired freezing, which can be restored by glucocorticoid administration [44].
According to Schwabe et al., psychobiological mechanisms of stress-resilience are associated with
an active response to stress stimuli and a bias toward the use of stimulus–response (S–R) learning;
the striatum is a key player in the implementation of S–R learning, and this was indirectly confirmed
by data from striatal NMR spectroscopy [2]. Our method, as applied here, has revealed an increase in
striatal Glu+Gln in AFR compared to APR rats. The elevation of the major excitatory neurotransmitter
Glu in AFR animals reflects activation of the striatum, which corresponds to S–R learning in rats with
an active coping style [2,25,27]. Interestingly, the striatum showed no changes in Glu+Gln during
early stress, but rather, a significant increase was observed in the late period, relative to changes in
neutral runs [32]. An opposite dynamic response to stress was seen in other regions, including the
hippocampus, with increases in neural activity in the early period, followed by reduced activity later;
these changes are suggestive of an adaptive or habituation network part of the adaptive response
to stress [32]. The observed increase in striatal activity may buffer against the effect of negative
experiences on the development of post-traumatic manifestations [45]. This would explain the low
anxiety levels we observed in AFR rats.
Elevated levels of the inactive GC 11-dehydrocorticosterone were detected in the adrenal glands of
AFR rats. Taking into account that the rat adrenal glands have much higher 11βHSD2 than 11βHSD1
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activity [46], we could not rule out a decrease of CORT release by 11βHSD2 activation preventing its
secretion. The complexity of 11βHSD action has been highlighted by studies of 11βHSD1 knockout
mice, which display compensatory adrenal hyperplasia and increased basal levels of corticosterone,
despite the presumed absence of hepatic 11-dehydrocorticosterone to corticosterone conversion [47].
In addition, 11βHSD2 provides protection of the target tissues and modulates circulating levels of
CORT, as shown in birds [48]. Moreover, peripheral antagonism of the 11βHSD system has a greater
impact on circulating glucocorticoid levels than central control during the stress response, and this
system, in turn, could be influenced by ACTH, which caused a 5–10 fold increase in 11ßHSD2 mRNA in
primary cultures of rat adrenocortical cells [49]. The unique advantage of such local regulation is that
the adrenal cortex could rapidly and reversibly modify the secreted ratio of the inactive to the active
form of CORT. A rapid transition of this ratio might serve as an advantage of AFR over APR animals by
preventing negative effects associated with a long-term decrease in GC levels. As the adrenal cortices
express both 11βHSD1 and 11βHSD2, we postulate that both activating and inactivating reactions may
take place, representing a previously unsuspected rapid regulatory mechanism of the stress response.
4. Materials and Methods
Experiments were performed on 29 genetically similar white male Sprague Dawley rats,
each weighing 240–260 g (age of 8–9 weeks), obtained from the specific-pathogen-free (SPF) vivarium of
the Institute of Cytology and Genetics SB RAS (Novosibirsk, Russian Federation). Rats were housed in
sibling pairs in standard ventilated cages (IVC BlueLine, Tecniplast, Italy). Water and granulated forage
(Sniff, Soest, Germany) were given ad libitum. Animals were kept in a 14 h light (2 a.m. to 4 p.m.) and
10 h dark (4 p.m. to 2 a.m.) cycle, temperature (22–24 ◦C), and relative humidity (40–50%) controlled
environment. The behavioral task was always initiated at the start of the dark cycle, when rodents are
most active.
All animal experiments conformed to the requirements of the Council for International
Organizations of Medical Sciences (CIOMS) and the International Council for Laboratory Animal
Science (ICLAS), as described in “International Guiding Principles for Biomedical Research Involving
Animals” (2012). The handling of all animals was identical. The study protocol was approved by the
Committee for Bioethics and Humane Treatment of Laboratory Animals at South Ural State University,
Russia (Project 0425-2018-0011 from 17 May 2018, protocol number 27/521).
4.1. Experimental Procedure
Following exposure to the predator odor stimulus, the rat phenotypic behavioral pattern
was classified into one of two groups: allostatically active flight/fight response (AFR), i.e., rats
exhibiting a “stimulus–response” behavior pattern, and allostatically freezing/passive response (APR)
groups [3,50,51].
For the PSS protocol, rats were exposed to cat urine scent in a Petri dish with litter for 10 min
daily for 10 days (21 rats were submitted to stress exposure; 8 control rats were exposed to a neutral
scent). Repeated exposure to the PSS may be a more accurate model of human PTSD than the single
acute exposure approach, granted that it minimizes the effect of confounding factors, such as the
concentration of pheromones in each individual urine scent exposure [3,52]. All procedures were
performed between 1:00 and 2:00 p.m. During the scent exposure protocol, stress-related behavior
was captured daily via web-camera. Behavioral evaluation was conducted via 3D animal tracking
system “EthoStudio” [53]. The evaluator of the behavior had not previously worked with any rats in
our groups. Recorded variables included the time spent in open and closed arms of the maze and the
number of entries into the open and closed arms.
The timeline for modeling PSS, evaluating stress-related behavior and anxiety, and measuring
of metabolites (CORT, Glu+Gln and 11-dehydrocorticosterone) in plasma, brain, and adrenal glands,
respectively, was as follows:
1. Days 1–10: PSS;
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2. Days 11–22: rest;
3. Day 23: elevated plus maze test;
4. Day 27: striatum metabolite measurement by MRS;
5. Day 28: euthanasia, harvesting of blood and organs.
4.2. Behavioral Activity
Video recordings of PSS sessions were made in the home cages. The presence or absence of
behavioral responses was recorded daily. The frequencies of freezing, grooming, sniffing of stimuli,
climbing on stimuli, and tearing of protective cover of stimuli were used for classification of rats as AFR
and APR. The presence of the response in one session was marked with “1”, while the lack of a response
was marked as “0”. Apart from registration of the daily changes of the observed behavioral responses,
we also summarized the frequencies of these behavioral responses over 10 days. The predator stress
outcome was evaluated using the elevated plus maze test, using the standard elevated plus maze
(EPM) test apparatus TS0502-R3 (OpenScience, Russia) [54,55]. Variables recorded included time
spent in open and closed arms of the maze and the number of entries into the open and closed arms.
While Table 1 demonstrates the measurements of the maze, Figure 1 reflects the dynamics of rat
behavior in home cages during the 10 days of PSS.
4.3. Magnetic Resonance Spectroscopy (MRS)
Rat striatum neurometabolites (Figure 2) were measured on a horizontal tomograph with
a magnetic field of 11.7 tesla (Bruker, Biospec 117/16 USR, Germany). The rats were anesthetized with
gas (isoflurane; Baxter Healthcare Corp., Deerfield, IL, USA) using a Univentor 400 Anesthesia Unit
(Univentor, Zejtun, Malta). The tomographic table contained a water circuit that maintained a surface
temperature of 30 ◦C to preserve animal body temperature during the test. A pneumatic respiration
sensor (SA Instruments, Stony Brook, NY), placed under the lower body, controlled the depth of
anesthesia. Proton spectra of the rat striatum were recorded with transmitter volume (T11232V3) and
rat brain receiver surface (T11425V3) using 1 Hz radiofrequency coils (Bruker, Ettlingen, Germany).
High-resolution T2-weighted images of the rat brain in three (axial, sagittal, and coronal) dimensions
(section thickness, 0.5 mm; field of view, 2.5 × 2.5 cm for axial and 3.0 × 3.0 cm for sagittal and coronal
sections; matrix of 256 × 256 dots) were recorded by rapid acquisition with relaxation enhancement
(TurboRARE), with the pulse sequence parameters TE = 11 ms and TR = 2.5 s for correct positioning of
the spectroscopic voxels. Voxel dimension was 3.0 × 3.0 × 3.0 mm for the striatum. Voxel was manually
placed according to a structural T2-weighted MRI image (Figure 5). All proton spectra were recorded
by spatially localized single-voxel stimulated echo acquisition mode (STEAM) spectroscopy, with the
following pulse sequence parameters: TE = 3 ms, TR = 5 s, and 120 accumulations. Uniformity of
the magnetic field was tuned within the selected voxel using FastMap [56] before each spectroscopic
recording. The water signal was inhibited with a variable pulse power and optimized relaxation delays
(VAPOR) sequence [57].







Figure 5. MRS measurements in the striatal region. The labeled pink area indicated the: “Voxel position
during 1H MRS of the striatum”.
4.4. Processing of 1H Spectra
The experimental 1H magnetic resonance spectra were processed, and the quantitative composition
of metabolites was determined with a custom-made program similar to that of the LC Model software
package [58,59]. The baseline correction was conducted automatically by the program to determine the
spectral baseline for fitting of the spectrum obtained by 1H MRS. The process of fitting was presented
on the real-time plot, and the fitted data were stored in numerical form.
4.5. Hormonal Measurements
Between 11:00 a.m. and 1:00 p.m. on experimental day 28, rats were sacrificed by decapitation,
and blood samples were collected in tubes with heparin. Blood samples (Figure 3) were then centrifuged
at 3000 rpm at 4 ◦C for 15 min. Plasma samples were aliquoted and stored in a −80 ◦C freezer until
use. After thawing, plasma CORT concentrations were measured by ELISA (Cusabio ELISA Kit, Texas,
USA) as per manufacturer’s instructions. The assay sensitivity was 0.25 ng/mL, and the intra- and
interassay coefficients of variation were both <5%.
High-performance liquid chromatography (HPLC) using the micro-column liquid chromatograph
Milikhrom-1 (NPO “Nauchpribor”, Orel, Russia) for the evaluation of corticosteroids (CORT and
11-dehydrocorticosterone) in rat adrenal glands (Figure 4) was carried out on experimental day 28.
The entire procedure of adrenal CORT extraction, measurements, and validation was previously
described in detail [60,61]. The adrenal glands were weighed, transferred into a glass homogenizer,
placed into an ice bath, and thoroughly homogenized in 1 mL of cold acetone. The homogenates
were transferred to plastic tubes, and the samples were centrifuged at 2000 g at 4 ◦C for 15 min.
The supernatants were then poured into a plastic tube and evaporated in a nitrogen flow at
40 ◦C. The residues were dissolved in 24 µL of a 65% solution of CH3OH in water. The injection
volumes were 8 µL. Determinations of corticosteroid hormones were carried out using micro-column
high-performance liquid chromatography (HPLC) [62]. Chromatographic conditions were as follows:
steel column 2 × 62 mm in size, packed with Silasorb C18 SPH 8 (5 µm) as sorbent, gradient elution
with acetonitrile in water from 30 to 55% (v/v), eluting rate of 100 µL/min, and UV detection at 240 and
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260 nm. The wavelengths were chosen because of the absorption spectrum of steroid hormones: 240 nm
corresponds to the maximal absorption of the majority of corticosteroid hormones, while 260 nm
corresponds to half of the maximal absorption. Chromatographic information was processed with the
help of CHROM software (EcoNova, Institute of Chromatography, Novosibirsk, Russia).
Hormone identification was performed by comparing retention times and spectral ratios of
endogenous corticosteroids and synthetic standards. The amounts of the corticosteroids were
determined in nanograms per mg of tissue (ng/mg) using calibration curves plotted individually
for each hormone under investigation. Chromatographic separation of a mixture of standards (a)
(C = 10 ng/µL, 5 µL was taken for the analysis) and adrenal extracts (b) is shown in Figure 6.
 
(a)                                       (b) 
β
Figure 6. Chromatographic separation of a mixture of standards (a): 7-aldosterone,
9 – 11-dehydrocorticosterone, 10-corticosterone, and 16 – 11-desoxycorticosterone; and adrenal extracts
(b): 5-aldosterone, 11 – 11-dehydrocorticosterone, 12-corticosterone, and 16 – 11-desoxycorticosterone.
The black line corresponds to absorption at 240 nm, the red line to absorption at 260 nm. The y-axis is
absorption (A) in absorption units (AU); the x-axis is time in min.
4.6. Data Analyses
Data were analyzed with SPSS 24, STATISTICA 10.0 and MS Excel software. Quantitative data
were presented as mean ± SEM. After having shown normal distribution by the Shapiro–Wilk test,
a one-way ANOVA with Fisher’s LSD post hoc tests and the Kruskal–Wallis with Bonferroni corrected
post hoc tests were used to compare all outcome measures between two groups (e.g., control vs. AFR,
control vs. APR, AFR vs. APR). p < 0.05 was considered significant.
5. Conclusions
The LHPA axis coordinates behavioral and physical responses to chronic stressors, with the
striatum acting as a player in the implementation of the active offensive behavior. GCs modulate the
activity of the striatum. In our study, we observed activation of the striatum, an important component
of an active behavioral strategy that was accompanied by decreased GC levels. This decrease was
seen in a relatively distant period from the timing of the stressor. Other investigators described
activation of the striatum at earlier time intervals relative to the timing of the stressor, which was
probably associated with elevated GC levels. Lower CORT levels in blood might be related to decreased
activity of the HPA axis and/or increased adrenal conversion to 11-dehydrocorticosterone. In the
latter case, we demonstrated a transient hypocorticosteronemia, which might quickly level out or
turn into hypercorticosteronemia. Our data might have some clinical implications suggesting that
individuals with more externalizing behaviors (more active offensive response to chronic stress),
have less anxiety and lower basal CORT levels compared to individuals with more internalizing
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behaviors (freezing/passive response to chronic stress), indicating a lower allostatic set-point with
higher resistance to stress in externalizing individuals.
6. Limitations of the Study
The main limitation of this study was that we did not investigate the activity and expression of
11βHSD1 and -2 in peripheral tissues beyond the adrenal glands. Further studies will examine this
issue to establish adrenal and non-adrenal factors that might regulate CORT metabolism. We should
also emphasize that CORT levels and patterns discussed here might not correspond to those that could
be observed after the initial exposure. Thus, according to Dopfel et al., in low-freezing (i.e., active)
animals, the CORT response immediately after stress exposure was heightened and prolonged and
had a delayed return to baseline, a pattern of CORT response that has been suggested as a marker
of maladaptation to stress in individuals who develop PTSD [9]. With time, this pattern of CORT
response may change through several processes, including changes in adrenal enzymatic activity,
as shown in this study.
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